Active

ZELLIK PHARMA

Switched

BE0881910538

Rechtspersoon Private limited company 1 establishment

Brusselsesteenweg 812, 1731 Asse Detailhandel in farmaceutische producten

Active for

20 year, 2 months

Financials

Financial year 2024

Gross margin

€ 393,644

▼ 37% vs 2023

Profit

Caution

€ -93,373

▼ 236% vs 2023

Debts

Low

€ 728,019

▲ 25% vs 2023

ZELLIK PHARMA from Asse, company number BE0881910538, closed financial year 2024 with a result of € -93,373 after tax. For that financial year ZELLIK PHARMA recorded a gross margin of € 393,644 and equity of € 442,566. Compared with financial year 2023, the result moved from € 68,565 to € -93,373. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2025.

What happened at ZELLIK PHARMA?

What happened at ZELLIK PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2024: loss of € 93,373 (▼ 236% vs 2023). Source: NBB ↗
  • Pharma Force NV became a director. NBB
  • Start of the company according to the CBE. KBO
  • New establishment in Dilbeek. KBO

In short

From € 115,718 profit in 2021 to € 93,373 loss in 2024.

Paid € 110,584 in corporate taxes since 2021.

Best year ever: 2021, with € 115,718 profit.

On average € 44,200 of value added per employee in 2024.

A new publication or filing at ZELLIK PHARMA? We notify you, reason included.

Follow ZELLIK PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Behind ZELLIK PHARMA is Pharma Force NV. Pharma Force NV is also behind Pharma2Care and PHARMA BASE.

See the full network in the app

Directors

According to the 2024 annual accounts

Pharma Force NV

Director · represented by Mathieu Peeters

Also active at: Pharma2Care, PHARMA BASE

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Brusselsesteenweg 812

1731 Asse

2.156.122.532

Elzenstraat 4

1702 Dilbeek

Active since 10 June 2006

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0881.910.538
VAT number
BE 0881.910.538
Registered office
Brusselsesteenweg 812, 1731 Asse
Names & denominations
ZELLIK PHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
16 June 2006
Peppol
Active · Active since 13 Jun 2025
Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Frequently asked questions

What is the enterprise number of ZELLIK PHARMA?
The enterprise number of ZELLIK PHARMA is BE0881910538.
What is the address of ZELLIK PHARMA?
The registered office of ZELLIK PHARMA is located at Brusselsesteenweg 812, 1731 Asse.
When was ZELLIK PHARMA founded?
ZELLIK PHARMA was founded on 16 June 2006.
What is the main activity of ZELLIK PHARMA?
The main activity of ZELLIK PHARMA is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does ZELLIK PHARMA have a website?
No website is currently known for ZELLIK PHARMA.
How much profit did ZELLIK PHARMA make in 2024?
ZELLIK PHARMA recorded a loss after taxes of € 93,373 in financial year 2024.
What is the revenue of ZELLIK PHARMA?
As a small company, ZELLIK PHARMA is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 393,644.
How many employees does ZELLIK PHARMA have?
According to the 2024 annual accounts, ZELLIK PHARMA has 8.9 full-time equivalents (FTE).
Where can I find the annual accounts of ZELLIK PHARMA?
ZELLIK PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of ZELLIK PHARMA?
According to the 2024 annual accounts, the directors of ZELLIK PHARMA are: Pharma Force NV.
Who owns ZELLIK PHARMA?
Behind ZELLIK PHARMA is Pharma Force NV. Pharma Force NV is also behind Pharma2Care and PHARMA BASE.